Technology | 2020.02.26
Hera BioLabs (“Hera”) and Demeetra Ag Bio (“Demeetra”) announce joint launch of Cas-CLOVER™ the “clean alternative to CRISPR/Cas9 for drug discovery and bioprocessing”
The companies are offering Cas-CLOVER in distinct fields of use: Demeetra is operating in the pharmaceutical/industrial bioprocessing space as well as agricultural biotechnology, while Hera is focused on products tools and services for research and drug discovery
(PRWeb February 26, 2020)
Read the full story at https://www.prweb.com/releases/hera_biolabs_hera_and_demeetra_ag_bio_demeetra_announce_joint_launch_of_cas_clover_the_clean_alternative_to_crispr_cas9_for_drug_discovery_and_bioprocessing/prweb16932231.htm
For more information, please visit
https://www.prweb.com/releases/hera_biol[...]ioprocessing/prweb16932231.htm
